Canagliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity.
Molecular Weight:
444.52
CAS Number:
[842133-18-0]
* VAT and and shipping costs not included. Errors and price changes excepted
